A judge has upheld findings from IP Australia that South Korean biotech ToolGen’s genome editing technology CRISPR is not patentable, but given the company one more chance to seek to amend its application.
Insurer Vero dragged into class action over combustible cladding
Top Robodebt bureaucrat suspended in wake of withering report
ACCC flags concerns with Coles acquisition of Saputo dairy plants
ACL’s $1.5B tie-up with Healius rings alarm bells for ACCC
Norton Rose snags class action ace from US, elevates arbitration expert
NSW government on hook for damages in light rail class action
A judge has found the state of NSW liable to compensate the lead plaintiffs in a class action brought on behalf of small businesses over the “substantial and unreasonable” interference caused by the construction of Sydney’s $3 billion light rail network, but he flagged “significant problems” in applying his findings to thousands of potential group members.